Targeted therapy in gynecologic cancers: Ready for prime time?

Simple item page
dc.contributor.authorSeoud, Muhieddine A.F.
dc.contributor.authorÅvall-Lundqvist, Elisabeth H.
dc.contributor.authorFujiwara, Keiichi
dc.contributor.departmentObstetrics and Gynecology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:07:58Z
dc.date.available2025-01-24T12:07:58Z
dc.date.issued2015
dc.identifier.doihttps://doi.org/10.1016/j.ijgo.2015.06.012
dc.identifier.eid2-s2.0-84944072329
dc.identifier.pmid26433672
dc.identifier.urihttp://hdl.handle.net/10938/31656
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofInternational Journal of Gynecology and Obstetrics
dc.sourceScopus
dc.subjectAntineoplastic agents
dc.subjectDrug design
dc.subjectFemale
dc.subjectGenital neoplasms, female
dc.subjectHumans
dc.subjectMolecular targeted therapy
dc.subjectNeoplasm staging
dc.subjectOvarian neoplasms
dc.subjectUterine cervical neoplasms
dc.subjectAntineoplastic agent
dc.subjectNicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor
dc.subjectAngiogenesis
dc.subjectAntiangiogenic therapy
dc.subjectArticle
dc.subjectCancer adjuvant therapy
dc.subjectCancer immunotherapy
dc.subjectCancer prognosis
dc.subjectCapillary density
dc.subjectDose densification
dc.subjectFemale genital tract cancer
dc.subjectHuman
dc.subjectMaintenance therapy
dc.subjectMolecularly targeted therapy
dc.subjectOvary cancer
dc.subjectPriority journal
dc.subjectProgression free survival
dc.subjectTumor microenvironment
dc.subjectUterine cervix cancer
dc.subjectCancer staging
dc.subjectPathology
dc.titleTargeted therapy in gynecologic cancers: Ready for prime time?
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2015-5053.pdf
Size:
132.52 KB
Format:
Adobe Portable Document Format
Download

Collections

Obstetrics and Gynecology